A detailed history of Grant transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Grant holds 47,691 shares of OCUL stock, worth $495,509. This represents 0.21% of its overall portfolio holdings.

Number of Shares
47,691
Previous 36,039 32.33%
Holding current value
$495,509
Previous $246,000 68.29%
% of portfolio
0.21%
Previous 0.13%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$6.45 - $9.23 $75,155 - $107,547
11,652 Added 32.33%
47,691 $414,000
Q2 2024

Jul 22, 2024

BUY
$4.2 - $8.69 $151,363 - $313,178
36,039 New
36,039 $246,000

Others Institutions Holding OCUL

About OCULAR THERAPEUTIX, INC


  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $800M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Grant Portfolio

Follow Grant and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grant, based on Form 13F filings with the SEC.

News

Stay updated on Grant with notifications on news.